Faculty Information - Takayuki Tsujioka

（Last updated : 2024-09-13 16:14:29）

Takayuki Tsujioka
Department Kawasaki Medical School Kawasaki Medical School, Department of Laboratory Medicine (Laboratory Hematology),

Position Associate Professor

■ BooK

2011/04

Application of laser scanning cytometry to clinical and laboratory hematology., Laser Scanning,Theory and Applications

■ Journal

1.	2013/02	Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines
2.	2012/06	Approach to new therapeutics: Investigation by the use of MDS-derived cell lines.Curr Pharm Design
3.	2011/01	The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma.
4.	2010/09	Ph clone recurrence after imatinib discontinuation for chronic myelogenous leukemia patients who had complete molecular remission.
5.	2010/04	Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis.
6.	2012/03	Rab27b regulates c-kit expression by controling the secretion of stem cell factor.
7.	2008/09	Validation of the revised 2008 WHO diagnostic criteria in 75 suspected cases of myeloproliferative neoplasm.
8.	2008/03	DNA ploidy and cell cycle analyses in the bone marrow cells of patients with megaloblastic anemia using laser scanning cytometry.
9.	2006/11	TRAIL expression up-regulated by interferon-gamma via phosphrylation of STAT1 induces myeloma cell death
10.	2006/05	The mechanisms of vitamin K2-induced apoptosis of myeloma cells.
11.	2006/05	Effects of peripheral cannabimoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils
12.	2004/11	Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.
13.	2004/07	Multiple Myeloma Complicated by Autoimmune Hemolytic Anemia.
14.	2004/05	Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells.
15.	2003/08	Expression of HER family receptors and effects of anti-HER2-antibody on human myeloma cell lines.
16.	2003/09	IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitor.
17.	2003/12	MLL/AF-1p Fusion in Therapy-Related Early Pre-B Acute Lymphoblastic Leukemia with a t(1;11)(p32;q23) Translocation Developing in the Relapse Phase of Acute Promyelocytic Leukemia.
18.	2018/08	An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS.
19.	2018/06	Utility of a Fluorescence Microscopy Imaging System for Analyzing the DNA Ploidy of Pathological Megakaryocytes Including 5q- Syndrome
20.	2016/09	Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.
21.	2016/07	Low neutrophil alkaline phosphatase score is a new aspect of calreticulin-mutated myeloproliferative neoplasms
22.	2015/11	Five-aza-2'-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells.
23.	2015/10	Analysis of heredirary elliptocytosis with decreased binding of eosin-5-maleimide to red blood cells
24.	2015/05	Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by DNA damage-induced G2/M arrest.
25.	2003/02	Expression of angiogenic factors including VEGFs and the effects of hypoxia and thalidomide on human myeloma cells.
26.	2003	Effects of All-trans retinoic acid (ATRA) on human myeloma cells.
Display 5 items
Display all(26)

■ Presentation

1.	2012/05/26	Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived cell lines （Poster notice，General）
2.	2016/05/13	Five-Aza-2’-Deoxycytidine-Induced Hypomethylation of Cholesterol 25-Hydroxylase Gene Is Responsible for Cell Death of Myelodysplasia/Leukemia Cells. （Poster notice，General）
3.	2015/05/20	Approach to the standardization of morphological diagnosis of the myelodysplastic syndromes in Japan （Poster notice，General）